Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Cardio

Date Submitted: Aug 7, 2025
Date Accepted: Feb 10, 2026

The final, peer-reviewed published version of this preprint can be found here:

Heart Rate Estimation Using the Galaxy Watch During Maximal Cardiopulmonary Exercise Testing: Cross-Sectional Validation Study

Inoue A, Soares JPF, Antunes-Santos F, Ferreira A, Gonçalves A, Alcântara JA, dos Santos MR

Heart Rate Estimation Using the Galaxy Watch During Maximal Cardiopulmonary Exercise Testing: Cross-Sectional Validation Study

JMIR Cardio 2026;10:e81917

DOI: 10.2196/81917

PMID: 15608475

PMCID: 13086260

Validity of Galaxy Watch for estimating heart rate during maximal cardiopulmonary exercise testing

  • Allan Inoue; 
  • João Paulo Ferreira Soares; 
  • Felipe Antunes-Santos; 
  • Alexandre Ferreira; 
  • Alberto Gonçalves; 
  • João Arthur Alcântara; 
  • Marcelo Rodrigues dos Santos

ABSTRACT

Background:

Photoplethysmography (PPG)–based smartwatches are increasingly used for continuous heart‑rate (HR) monitoring. Their accuracy has been demonstrated at rest or during low‑intensity activity, but data are scarce for maximal‑intensity exercise, when motion artefacts and rapid hemodynamic changes can degrade the PPG signal. Validating these devices under such demanding conditions is essential before they are applied to clinical exercise testing, athletic training, or remote health monitoring.

Objective:

The primary aim of this study was to evaluate the validity of the Samsung Galaxy Watch 6 (GW6) in estimating HR throughout a graded, maximal ramp cardiopulmonary exercise test (CPET) performed on a treadmill. A secondary aim was to explore whether measurement error varies across five predefined intensity zones (50–60 %, 60–70 %, 70–80 %, 80–90 %, and 90–100 % of the maximum HR determined individually for each participant).

Methods:

Fifty‑five healthy adults (30 men, 25 women; mean ± SD age = 30.3 ± 8.2 years) completed a symptom‑limited incremental treadmill protocol to volitional exhaustion. Simultaneous HR recordings were obtained from the GW6 (left arm) and a Polar H10 chest‑strap monitor, which served as the reference standards. For each intensity zone, the following agreement indices were computed: intraclass correlation coefficient (ICC), typical error of measurement expressed as a percentage of the mean (TEM %), and mean absolute percentage error (MAPE %). Bland–Altman analysis was performed to quantify the mean bias and 95% limits of agreement (LoA) between the GW 6 and the Polar H10. Statistical significance was set at p < 0.05.

Results:

Across the five intensity zones, GW6 HR values were consistently lower than the criterion Polar H10 values (Table 2). The ICC ranged from 0.49 (80–90 % HRmax, 95 % CI 0.26–0.67) to 0.70 (50–60 % HRmax, 95 % CI 0.54–0.81), indicating poor to moderate relative agreement. TEM increased with workload, from 2.97 bpm (95 % CI 2.50–3.66) at 50–60 % HRmax to 6.25 bpm (95 % CI 5.26–7.70) at 80–90 % HRmax; TEM % values were consistently low across all intensity zones (2.9 %–4.2 %). MAPE values were modest throughout, decreasing from 3.7 % ± 3.9 % at the lowest intensity zone to 1.9 % ± 3.7 % at 90–100 % HRmax. Bland–Altman analysis showed that the GW6 consistently underestimated HR compared with the Polar H10, with an overall mean bias of −2.67 bpm and wide limits of agreement (−16.90 to 11.57 bpm). This negative bias was present across all heart rate zones, with no proportional bias detected. Agreement was adequate for group-level comparisons but displayed substantial individual variability.

Conclusions:

The Samsung GW6 provides a good degree of validity for HR monitoring during maximal treadmill CPET in healthy young adults. Although measurement error increases modestly at near‑maximal workloads, absolute errors remain well within clinically acceptable thresholds. These findings support the potential use of GW6 as a convenient, non‑invasive alternative for HR tracking in laboratory‑based exercise testing.


 Citation

Please cite as:

Inoue A, Soares JPF, Antunes-Santos F, Ferreira A, Gonçalves A, Alcântara JA, dos Santos MR

Heart Rate Estimation Using the Galaxy Watch During Maximal Cardiopulmonary Exercise Testing: Cross-Sectional Validation Study

JMIR Cardio 2026;10:e81917

DOI: 10.2196/81917

PMID: 15608475

PMCID: 13086260

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.